Christine Ring - Jan 10, 2022 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role: General Counsel
Signature: /s/ Christine Ring
Stock symbol: NRIX
Transactions as of: Jan 10, 2022
Transactions value $: -$30,336
Form type: 4
Date filed: 1/11/2022, 03:10 PM
Previous filing: Dec 13, 2021
Next filing: Jan 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRIX	Common Stock	Options Exercise	$2.23K	+1.2K	+93.31%	$1.86^*	2.49K	Jan 10, 2022	Direct	F1
transaction	NRIX	Common Stock	Sale	-$32.6K	-1.2K	-48.27%	$27.14	1.29K	Jan 10, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRIX	Employee Stock Option (right to buy)	Options Exercise	$0	-1.2K	-1.18%	$0.00	100K	Jan 10, 2022	Common Stock	1.2K	$1.86	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2	The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Content

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

The option vests as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on August 9, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.